Noxopharm Ltd Asset Resilience Ratio

Latest as of December 2025: 1.92%

Noxopharm Ltd asset resilience ratio. Noxopharm Ltd (NOX) has an Asset Resilience Ratio of 1.92% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Noxopharm Ltd (NOX) defensive interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

AU$91.40K

≈ $64.67K USD Cash + Short-term Investments

Total Assets

AU$4.75 Million

≈ $3.36 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Noxopharm Ltd (2016–2023)

Asset resilience ratio of Noxopharm Ltd from 2016 to 2023. This chart shows how Noxopharm Ltd's Asset Resilience Ratio has changed over time. Read NOX liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Noxopharm Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Noxopharm Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$91.40K	1.92%
Short-term Investments	AU$0.00	0%
Total Liquid Assets	AU$91.40K	1.92%

Asset Resilience Insights

Limited Liquidity: Noxopharm Ltd maintains only 1.92% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Noxopharm Ltd Industry Peers by Asset Resilience Ratio

Compare Noxopharm Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	15.95%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	36.07%
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Verona Pharma PLC ADR NASDAQ:VRNA	Biotechnology	0.00%
3SBio Inc F:83B	Biotechnology	10.64%

Noxopharm Ltd Asset Resilience Ratio by Year (2016–2023)

Noxopharm Ltd asset resilience ratio by year from 2016 to 2023. The table below shows the annual Asset Resilience Ratio data for Noxopharm Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-06-30	0.00%	AU$0.00 ≈ $0.00	AU$10.13 Million ≈ $7.17 Million	--
2022-06-30	30.08%	AU$8.00 Million ≈ $5.66 Million	AU$26.59 Million ≈ $18.82 Million	+9.19pp
2021-06-30	20.90%	AU$10.00 Million ≈ $7.08 Million	AU$47.85 Million ≈ $33.86 Million	-46.76pp
2019-06-30	67.66%	AU$2.91 Million ≈ $2.06 Million	AU$4.30 Million ≈ $3.04 Million	-19.04pp
2018-06-30	86.69%	AU$12.61 Million ≈ $8.92 Million	AU$14.55 Million ≈ $10.29 Million	-0.20pp
2017-06-30	86.89%	AU$2.46 Million ≈ $1.74 Million	AU$2.83 Million ≈ $2.00 Million	+86.74pp
2016-06-30	0.15%	AU$9.56K ≈ $6.76K	AU$6.21 Million ≈ $4.39 Million	--

pp = percentage points

About Noxopharm Ltd

AU:NOX Australia Biotechnology

Market Cap

$7.61 Million

AU$10.75 Million AUD

Market Cap Rank

#27575 Global

#1351 in Australia

Share Price

AU$0.04

Change (1 day)

+0.00%

52-Week Range

AU$0.04 - AU$0.10

All Time High

AU$1.58